Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide

Annals of Allergy, Asthma and Immunology

Volumn 87, Issue 4, 2001, Pages 319-326

  Stelmach, Iwona ^a   Jerzynska, Joanna ^a   Kuna, Piotr ^b  

^a M Curie Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PLACEBO; SALBUTAMOL; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; ASTHMA; BLOOD; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

EID: 0034768135     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62247-8     Document Type: Article

References (39)

1. Immunobiology of asthma and rhinitis. Pathogenic factors and therapeutic options
2. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma
3. Measurement of serum and sputum eosinophil cationic protein concentrations in asthma
4. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: Relation to disease status and therapy
5. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma
6. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status
7. Peripheral blood markers: Evaluation and inflammation in asthma
8. Elevation of sIL-2R and IL-4, and non-elevation of INF-γ in sera from patients with allergic asthma
9. Soluble intercellular adhesion molecule-1 in sera of children with bronchial asthma exacerbation
10. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics
11. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids
12. Alternations of T-lymphocyte subsets, soluble IL-2 receptor and IgE in peripheral blood of children with acute asthma attacks
13. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics
14. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation
15. Long-term effects of budesonide or nedocromil in children with asthma
16. Effect of inhaled budesonide on lung function and airway inflammation
17. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
18. Interleukin 4 and soluble CD23 serum levels in asthmatic atopic children
19. Measurement characteristics of two asthma symptom diary scales for use in clinical trials
20. Standardization of spirometry
21. 20
22. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma
23. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma
24. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity
25. Bronchial hyperresponsiveness in asthmatic children: Correlation with macrophages and eosinophils in broncholavage fluid
26. Serum eosinophil cationic protein and bronchial responsiveness in pediatrics and adolescent asthma patients
27. Serum eosinophil cationic protein: Distribution and reproducibility in a randomly selected sample of men living in rural Norfolk, UK
28. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts
29. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma
30. Soluble interleukin-2 receptor and interleukin-4 in sera of asthmatic children before and after a prednisolone course
31. T cell subset and their soluble products regulate eosinophilia in allergic and nonallergic asthma
32. Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma
33. Induction of interleukin-4 and interleukin-5 expression in mast cells is inhibited by glucocorticoids
34. IL-5 induced airway eosinophilia - The key to asthma?
35. Increased allergen-specific Th2 responses in vitro in atopic subjects receiving subclinical allergen challenge
36. Theophylline - An immunomodulatory role in asthma?
37. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction
38. Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics